Is Adocia S.A. (ADOIF) a Buy, Sell, or Hold?
OTC : ADOIF
Adocia S.A.
$8.871 USD
$0 (0.0%)
- Volume
- 1K
- Average Volume
- 0
- Market Capitalization
- $103.66M
- P/E Ratio
- -3.87
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $8.87
- Year Low
- $8.87
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.19
Company Overview
OTC
Olivier Soula
Biotechnology
Healthcare
ADOIF
97
FR
USD
Liquidity Metrics
5.97
1.19
1.17
0.86
0.00
Sales & Valuation
$1.44M
50.87
49.32
-11.04
-0.35
Profitability
-$3.22
-$22.75M
-1124.81%
-1286.51%
-3796.57%
-58.31%
P/E Metrics
-3.87
0.07
0.07
Analyst Price Target & Rating
0/5
1 Analysts
%
Financial Health Scores
No financial score data available.
Key Metrics (TTM)
$66.68M
45.20
-4.34
1.19
-3796.57%
-142.92%
-22.56%
-9.06%
1342 days
Company Executives
| Name | Title |
|---|---|
| Valérie Danaguezian | Chief Financial Officer |
Poll Results
No votes yet today — be the first to share your view!
About Adocia S.A. (OTC:ADOIF) Stock
Adocia S.A., a biotechnology firm founded in Lyon, France, in 2005, operates at the clinical stage, focusing its research and development efforts on optimizing existing therapeutic proteins and peptides for the management of diabetes and various other metabolic conditions. The company's core innovation lies in its proprietary BioChaperone technological platform, specifically engineered to enhance the effectiveness and performance of therapeutic proteins. Adocia's product pipeline currently in clinical trials features several advanced insulin formulations. These include BioChaperone Lispro U100 and U200, which offer ultra-rapid action derived from rapid insulin lispro. Other notable candidates are BioChaperone Combo, a combination of both long-acting insulin glargine and rapid-acting insuli ... n lispro; BioChaperone LisPram, which pairs prandial insulin with pramlintide; BioChaperone Glucagon, an aqueous human glucagon formulation for treating low blood sugar; and M1Pram, a product based on a metabolite of insulin glargine and pramlintide. In addition to its clinical assets, Adocia boasts a strong preclinical pipeline. This includes bi-hormonal treatments such as BioChaperone AsPram, which combines rapid insulin aspart with pramlintide, and BioChaperone Glargine Liraglutidea, a fixed-dose combination of insulin glargine with a GLP-1 receptor analogue. The company is also exploring multihormonal solutions for obesity, including BioChaperone GluExe (glucagon and exenatide), PramExe (pramlintide and exenatide), and BioChaperone PramGluExe, a triple therapy comprising pramlintide, glucagon, and exenatide. Globally, Adocia has established a strategic partnership with Tonghua Dongbao Pharmaceutical Co., Ltd. This collaboration aims to develop and bring to market BioChaperone Lispro and BioChaperone Combo throughout China, as well as in other regions across Asia and the Middle East.
Frequently Asked Questions
-
What is the current Adocia S.A. (ADOIF) stock price?
-
Adocia S.A.(OTC:ADOIF) stock price is $8.871 in the last trading session. During the trading session, ADOIF stock reached the peak price of $8.871 while $8.871 was the lowest point it dropped to. The percentage change in ADOIF stock occurred in the recent session was 0.0% while the dollar amount for the price change in ADOIF stock was $0.
-
ADOIF's industry and sector of operation?
-
The OTC listed ADOIF is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of ADOIF?
-
Valérie Danaguezian | Chief Financial Officer
|
|
|
| -
How many employees does ADOIF have?
-
Number of ADOIF employees currently stands at 97. ADOIF operates from 115 Avenue Lacassagne, Lyon, None 69003, FR.
-
Link for ADOIF official website?
-
Official Website of ADOIF is: https://www.adocia.com
-
How do I contact ADOIF?
-
ADOIF could be contacted at phone #33 4 72 61 06 10 and can also be accessed through its website. ADOIF operates from 115 Avenue Lacassagne, Lyon, None 69003, FR.
-
How many shares of ADOIF are traded daily?
-
The average number of ADOIF shares traded daily for last 3 months was 0.
-
What is the market cap of ADOIF currently?
-
The market value of ADOIF currently stands at $103.66M with its latest stock price at $8.871